Catalyst Pharmaceutical Partners (CPRX)

[homdance]

Form 8-K for CATALYST PHARMACEUTICAL PARTNERS, INC.

29-Aug-2013

Change in Directors or Principal Officers, Other Events, F


Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On August 28, 2013, Catalyst Pharmaceutical Partners, Inc. ("Company") and its Chairman, President and Chief Executive Officer, Patrick J. McEnany, entered into an amendment to Mr. McEnany's employment agreement with the Company extending the term of such agreement for an additional three year period. Mr. McEnany's employment agreement with the Company now expires on November 8, 2016. All of the other terms of Mr. McEnany's employment agreement with the Company remain the same.

A copy of Amendment No. 4 to Mr. McEnany's employment agreement with the Company is attached hereto as Exhibit 10.1 and is incorporated herein by reference. The description of Amendment No. 4 that is set forth above is qualified in its entirety by reference to such amendment.



Item 8.01 Other Events
On August 28, 2013, the Company received approximately $1,378,000 upon the exercise of common stock purchase warrants to purchase an aggregate of 1,297,500 shares of the Company's common stock. A portion of the warrants that were exercised were originally issued in the Company's October 2011 registered direct offering, and the balance of the warrants that were exercised were issued in the Company's May 2012 public offering. The shares of common stock issued upon the exercise of these warrants are fully registered under the Securities Act of 1933.



Item 9.01 Financial Statements and Exhibits
(d) Exhibits

10.1 Amendment No. 4 to Employment Agreement between the Company and Patrick J.
McEnany, dated August 28, 2013




http://biz.yahoo.com/e/130829/cprx8-k.html